AtriCure, Inc. (ATRC)
52.62
+3.70
(+7.56%)
USD |
NASDAQ |
Sep 02, 16:00
52.62
0.00 (0.00%)
After-Hours: 18:50
AtriCure Research and Development Expense (TTM) : 94.05M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 94.05M |
| March 31, 2026 | 91.90M |
| December 31, 2025 | 90.17M |
| September 30, 2025 | 89.62M |
| June 30, 2025 | 87.69M |
| March 31, 2025 | 83.82M |
| December 31, 2024 | 81.90M |
| September 30, 2024 | 80.50M |
| June 30, 2024 | 80.65M |
| March 31, 2024 | 78.43M |
| December 31, 2023 | 73.92M |
| September 30, 2023 | 66.87M |
| June 30, 2023 | 61.68M |
| March 31, 2023 | 59.04M |
| December 31, 2022 | 57.34M |
| September 30, 2022 | 57.40M |
| June 30, 2022 | 53.51M |
| March 31, 2022 | 50.92M |
| December 31, 2021 | 48.51M |
| September 30, 2021 | 45.57M |
| June 30, 2021 | 44.86M |
| March 31, 2021 | 42.70M |
| December 31, 2020 | 43.07M |
| September 30, 2020 | 45.30M |
| June 30, 2020 | 44.87M |
| Date | Value |
|---|---|
| March 31, 2020 | 44.64M |
| December 31, 2019 | 41.23M |
| September 30, 2019 | 36.59M |
| June 30, 2019 | 34.99M |
| March 31, 2019 | 33.84M |
| December 31, 2018 | 34.72M |
| September 30, 2018 | 33.99M |
| June 30, 2018 | 33.40M |
| March 31, 2018 | 33.65M |
| December 31, 2017 | 34.14M |
| September 30, 2017 | 36.29M |
| June 30, 2017 | 36.59M |
| March 31, 2017 | 36.81M |
| December 31, 2016 | 35.82M |
| September 30, 2016 | 33.72M |
| June 30, 2016 | 31.96M |
| March 31, 2016 | 28.70M |
| December 31, 2015 | 25.74M |
| September 30, 2015 | 22.97M |
| June 30, 2015 | 21.50M |
| March 31, 2015 | 20.21M |
| December 31, 2014 | 18.60M |
| September 30, 2014 | 17.25M |
| June 30, 2014 | 15.46M |
| March 31, 2014 | 13.94M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp. | 2.153B |
| Abbott Laboratories | 3.128B |
| AngioDynamics, Inc. | 29.45M |
| Alphatec Holdings, Inc. | 76.69M |
| Baxter International, Inc. | 480.00M |